Expansion target Schülke & Mayr has recently acquired Redditch Medical Ltd, signaling ongoing expansion and a growth strategy in contamination control and infection prevention solutions. This presents a sales opportunity to offer enhanced cleanroom and disinfection products, services, and training to their integrated portfolio and new regions.

Geographic growth With operations across Germany, France, Brazil and distribution in over 100 countries via 20 subsidiaries and partners, there is strong potential to introduce scalable infection prevention, skin care, and preservative solutions in emerging markets and to support regional manufacturing with localized formulations.

Healthcare focus A core emphasis on healthcare, infection prevention, and direct patient care, along with brands like octenisept and mikrozid, indicates receptivity to advanced sterilization, antiseptic protocols, and hospital hygiene product lines, including training and implementation services.

Sustainability push Private equity ownership with a stated goal to invest in sustainability and innovation suggests openness to sustainable packaging, green chemistry, and efficiency improvements in manufacturing and supply chain, creating opportunities for lifecycle cost reductions and certifications.

Technology enablement Existing tech stack highlights SAP SuccessFactors and digital presence with global reach, implying opportunities to deliver digitized compliance, training, supplier management, and data-driven infection control solutions that integrate with their ERP and e-commerce channels.